Budimir S. Drakulic
Chief Tech/Sci/R&D Officer at BIOSIG TECHNOLOGIES, INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Frederick Hrkac | M | 58 | 2 years | |
| Lora Mikolaitis | F | 51 | 15 years | |
| Steven Abelman | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jeffrey O'Donnell | M | 64 | 10 years | |
| Kenneth Londoner | M | 57 | 15 years | |
| Greg Cash | M | 66 | 3 years | |
| Marvin Fink | M | 88 |
Signalife, Inc.
 Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | 3 years |
| David J. Drachman | M | 66 | - | |
| James Barry | M | 64 | 3 years | |
| Patrick Gallagher | M | 59 | 10 years | |
| Andrew Filler | M | 56 | 4 years | |
| Roy Tanaka | M | 75 | 7 years | |
| James Klein | M | 59 | 2 years | |
| Donald Foley | M | 73 | 9 years | |
| Kalyanam Shivkumar | M | 56 | 2 years | |
| William Uglow | M | 76 | - | |
| Jonathan Steinhouse | M | 57 | - | |
| Natasha Drapeau | F | - | 5 years | |
| Tiffini Wittwer | F | - | - | |
| Martha Pease | F | 66 | 2 years | |
| Zachary Koch | M | - | 2 years | |
| Anthony Zook | M | 63 | 2 years | |
| Jerome Zeldis | M | 74 | 1 years | |
| Pamela M. Bunes | F | 61 |
Signalife, Inc.
Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | 2 years |
| David Weild | M | 67 | 9 years | |
| Asher Holzer | M | 74 | - | |
| Samuel Navarro | M | 68 | 3 years | |
| Lowell T. Harmison | M | 87 |
Signalife, Inc.
Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | - |
| Steven Chaussy | M | 70 | 12 years | |
| John Kowalski | M | - | 2 years | |
| Robert C. Scherne | M | 67 |
Signalife, Inc.
Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | - |
| MaryAnn Edzards | F | - | 2 years | |
| Olivier Chaudoir | M | - | 3 years | |
| Manasi Patwardhan | F | - | 3 years | |
| Brian McLaughlin | M | - | - | |
| Julie Stephenson | F | - | - | |
| Andrew Gornell Ballou | M | - | 5 years | |
| Gray Fleming | M | 47 | 3 years | |
| John Sieckhaus | M | 56 | 2 years | |
| Steven Creviston | M | 60 |
Teledyne Electronic Technologies
| 7 years |
| Barry Keenan | M | - | 2 years | |
| Steven Buhaly | M | 67 | 1 years | |
| Jay A. Johnson | M | 63 |
Signalife, Inc.
Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | 1 years |
| Seth Fischer | M | 68 | 6 years | |
| Jay Millerhagen | M | - | 2 years | |
| Sasha Gentling | F | - | 3 years | |
| Ellsworth Roston | M | 101 |
Signalife, Inc.
Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | 7 years |
| Joseph Rafferty | M | 66 | - | |
| Jennifer Black | F | 68 |
Signalife, Inc.
Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | 6 years |
| Brenda Castrodad | F | - | 2 years | |
| Robert G. Koblin | M | 92 |
Signalife, Inc.
Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | 2 years |
| Kevin F. Pickard | M | 59 |
Signalife, Inc.
Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | 3 years |
| Charles H. Harrison | M | 81 |
Signalife, Inc.
Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | 2 years |
| William Robert Matthews | M | 69 |
Signalife, Inc.
Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | 5 years |
| Norma Provencio | F | 67 |
Signalife, Inc.
Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | - |
| Rodney Hildebrandt | M | - |
Signalife, Inc.
Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | 1 years |
| Katie Freshwater | F | - | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 57 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Budimir S. Drakulic
- Personal Network
